VA
DTIL icon

Verdad Advisers’s Precision BioSciences DTIL Stock Holding History

Verdad Advisers’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
+13,527
New +$95.2K 0.1% 186

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Verdad Advisers's DTIL Position: Q2 2026 in Review

Verdad Advisers opened a new position in Precision BioSciences (DTIL) in Q2 2026: 13,527 shares worth $106K. The stake represents 0.1% of the portfolio and ranks #186 among its holdings.

95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Verdad Advisers held 13,527 shares of Precision BioSciences worth $106K as of Q2 2026.
  • Precision BioSciences was a new Verdad Advisers position in Q2 2026.
  • Precision BioSciences made up 0.1% of Verdad Advisers's portfolio in Q2 2026, its #186 holding.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.